vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Upland Software, Inc.（UPLD）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Upland Software, Inc.的1.5倍（$75.5M vs $49.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -27.5%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $7.2M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -16.5%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Upland Software是全球云原生企业工作管理解决方案提供商，旗下产品覆盖项目组合管理、客户互动、IT服务管理、财务流程自动化等领域，服务北美、欧洲、亚太各行业不同规模的企业客户。
PBYI vs UPLD — 直观对比
营收规模更大
PBYI
是对方的1.5倍
$49.3M
营收增速更快
PBYI
高出55.2%
-27.5%
自由现金流更多
PBYI
多$7.2M
$7.2M
两年增速更快
PBYI
近两年复合增速
-16.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $49.3M |
| 净利润 | — | — |
| 毛利率 | 69.3% | 76.5% |
| 营业利润率 | 22.7% | 14.5% |
| 净利率 | — | — |
| 营收同比 | 27.7% | -27.5% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.26 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIUPLD
| Q4 25 | $75.5M | $49.3M | ||
| Q3 25 | $54.5M | $50.5M | ||
| Q2 25 | $52.4M | $53.4M | ||
| Q1 25 | $46.0M | $63.7M | ||
| Q4 24 | $59.1M | $68.0M | ||
| Q3 24 | $80.5M | $66.7M | ||
| Q2 24 | $47.1M | $69.3M | ||
| Q1 24 | $43.8M | $70.7M |
净利润PBYIUPLD
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $-1.1M | ||
| Q2 25 | $5.9M | $-13.0M | ||
| Q1 25 | $3.0M | $-25.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $-1.7M | ||
| Q2 24 | $-4.5M | $-11.4M | ||
| Q1 24 | $-4.8M | $-96.1M |
毛利率PBYIUPLD
| Q4 25 | 69.3% | 76.5% | ||
| Q3 25 | 77.7% | 76.9% | ||
| Q2 25 | 76.5% | 74.8% | ||
| Q1 25 | 77.1% | 71.6% | ||
| Q4 24 | 76.4% | 70.8% | ||
| Q3 24 | 63.9% | 70.5% | ||
| Q2 24 | 77.4% | 70.5% | ||
| Q1 24 | 75.5% | 70.2% |
营业利润率PBYIUPLD
| Q4 25 | 22.7% | 14.5% | ||
| Q3 25 | 17.6% | 10.6% | ||
| Q2 25 | 12.7% | -13.2% | ||
| Q1 25 | 8.7% | -1.7% | ||
| Q4 24 | 22.6% | -2.9% | ||
| Q3 24 | 27.4% | -5.0% | ||
| Q2 24 | -4.6% | -7.7% | ||
| Q1 24 | -5.3% | -129.6% |
净利率PBYIUPLD
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | -2.2% | ||
| Q2 25 | 11.2% | -24.4% | ||
| Q1 25 | 6.5% | -40.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | -2.6% | ||
| Q2 24 | -9.6% | -16.5% | ||
| Q1 24 | -11.0% | -135.9% |
每股收益（稀释后）PBYIUPLD
| Q4 25 | $0.26 | $0.01 | ||
| Q3 25 | $0.17 | $-0.09 | ||
| Q2 25 | $0.12 | $-0.51 | ||
| Q1 25 | $0.06 | $-0.97 | ||
| Q4 24 | $0.40 | $-0.30 | ||
| Q3 24 | $0.41 | $-0.12 | ||
| Q2 24 | $-0.09 | $-0.47 | ||
| Q1 24 | $-0.10 | $-3.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $29.4M |
| 总债务越低越好 | $22.7M | $232.4M |
| 股东权益账面价值 | $130.3M | $-48.4M |
| 总资产 | $216.3M | $413.2M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIUPLD
| Q4 25 | $97.5M | $29.4M | ||
| Q3 25 | $94.4M | $22.8M | ||
| Q2 25 | $96.0M | $41.0M | ||
| Q1 25 | $93.2M | $33.7M | ||
| Q4 24 | $101.0M | $56.4M | ||
| Q3 24 | $96.7M | $59.7M | ||
| Q2 24 | $96.8M | $232.4M | ||
| Q1 24 | $107.2M | $231.6M |
总债务PBYIUPLD
| Q4 25 | $22.7M | $232.4M | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | $290.2M | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIUPLD
| Q4 25 | $130.3M | $-48.4M | ||
| Q3 25 | $115.3M | $-47.3M | ||
| Q2 25 | $104.7M | $-42.4M | ||
| Q1 25 | $97.1M | $-37.8M | ||
| Q4 24 | $92.1M | $-18.3M | ||
| Q3 24 | $71.1M | $907.0K | ||
| Q2 24 | $48.5M | $6.5M | ||
| Q1 24 | $51.0M | $20.1M |
总资产PBYIUPLD
| Q4 25 | $216.3M | $413.2M | ||
| Q3 25 | $202.9M | $409.1M | ||
| Q2 25 | $194.9M | $441.7M | ||
| Q1 25 | $196.2M | $457.0M | ||
| Q4 24 | $213.3M | $529.5M | ||
| Q3 24 | $220.7M | $554.9M | ||
| Q2 24 | $205.0M | $739.9M | ||
| Q1 24 | $214.1M | $754.9M |
负债/权益比PBYIUPLD
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $7.3M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $7.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 14.7% |
| 资本支出强度资本支出/营收 | 0.0% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $24.4M |
8季度趋势，按日历期对齐
经营现金流PBYIUPLD
| Q4 25 | $14.4M | $7.3M | ||
| Q3 25 | $9.7M | $6.9M | ||
| Q2 25 | $14.1M | $3.3M | ||
| Q1 25 | $3.6M | $8.3M | ||
| Q4 24 | $15.6M | $9.3M | ||
| Q3 24 | $11.0M | $4.3M | ||
| Q2 24 | $1.0M | $5.5M | ||
| Q1 24 | $11.2M | $5.1M |
自由现金流PBYIUPLD
| Q4 25 | $14.4M | $7.2M | ||
| Q3 25 | $9.7M | $6.7M | ||
| Q2 25 | $14.1M | $2.7M | ||
| Q1 25 | $3.6M | $7.9M | ||
| Q4 24 | $15.6M | $9.0M | ||
| Q3 24 | $11.0M | $4.2M | ||
| Q2 24 | $1.0M | $5.2M | ||
| Q1 24 | — | $4.9M |
自由现金流率PBYIUPLD
| Q4 25 | 19.1% | 14.7% | ||
| Q3 25 | 17.7% | 13.2% | ||
| Q2 25 | 26.8% | 5.0% | ||
| Q1 25 | 7.7% | 12.4% | ||
| Q4 24 | 26.4% | 13.3% | ||
| Q3 24 | 13.7% | 6.3% | ||
| Q2 24 | 2.1% | 7.5% | ||
| Q1 24 | — | 7.0% |
资本支出强度PBYIUPLD
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.1% | 0.7% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.0% | 0.3% |
现金转化率PBYIUPLD
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
